Cumulative life course impairment in melanoma and nonmelanoma skin cancer.
Patients with skin cancer remain at risk for disease progression or relapse for many years. Therefore, skin cancer may be considered a chronic, life-threatening disease. It could impact on patients lifestyles and social and professional activities. Although no direct study of cumulative life course impairment (CLCI) in skin cancer patients has been carried out, a few studies suggest that skin cancer may strongly impair quality of life and eventually determine a significant CLCI (melanoma more than nonmelanoma skin cancer). Obviously, the life course of patients with melanoma at an advanced stage of the disease may change considerably. A number of cancer-associated problems may determine a CLCI, including familial or professional changes and a reduction of life expectancy may eventually lead to social withdrawal and depressive disorders. Even patients with a low stage disease may experience an important impairment of quality of life and in some cases a CLCI. Some skin cancer patients may have physical and psychological after effects from their cancer surgery. Several patients complain about lymphedema, discomfort experienced from wearing surgical stockings, and diminished range of physical motion postsurgery. A few are concerned about their body image due to surgical scars, and they may consider changing their job position because of the supposed negative impact of scars in visible sites on their ability to perform their job. Some female melanoma survivors may have a reduced desire of having children in the future.